A groundbreaking advancement by a team of scientists in Australia—led by Indian-origin researchers—could dramatically change ...

The portrayal of uncaring scientists without any thought for the animals being used in their research is far from the truth.

Prescription price controls and importing inferior medications will hurt both patients and America’s standards. We should ...

Microsoft has unveiled BioEmu, an advanced AI tool that can simulate protein behavior in mere hours—work that usually takes ...

Ichnos Glenmark Innovation & AbbVie ink exclusive global licensing agreement for ISB 2001: New York Saturday, July 12, 2025, 12:00 Hrs [IST] IGI Therapeutics SA, a wholly owned su ...

Amber Salzman, Ph.D., CEO at Epicrispr Biotechnologies, joined the Business of Biotech live in Boston to talk about ...

Cindy Rose, Microsoft's chief operating officer for global enterprise sales, is leaving the tech behemoth to become CEO ...

The U.S. market is currently experiencing a mix of volatility and optimism, with investor sentiment being influenced by renewed tariff threats and record highs in major indices like the S&P 500 and ...

Why a fundamental reimagining of how clinical studies operate is still necessary to achieve a true paradigm shift—and shed ...

I joined other leaders from academic medical centers and research institutions in Washington, D.C., to talk with policymakers about the urgent need for continued federal investments in health care and ...

Disclaimer: This news article is a direct feed from ANI and has not been edited by the News Nation team. The news agency is ...

New Delhi, Jul 11 (PTI) Shares of Glenmark Pharmaceuticals Ltd ended 14.51 per cent higher on Friday after the firm announced signing an up to USD 2-billion deal with AbbVie to commmercialise its ...